These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2218924)

  • 1. [A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis].
    Tov NL; Sidorova LD; Valentik MF; Movchan EA; Savitskaia IV; Nekipelova VI; Dorofeev SB; Nesina IA
    Ter Arkh; 1990; 62(6):37-42. PubMed ID: 2218924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II
    Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Sheveleva LA
    Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Biriukova LS; Makurov AI
    Ter Arkh; 1992; 64(8):47-50. PubMed ID: 1440396
    [No Abstract]   [Full Text] [Related]  

  • 6. [Some problems of the therapy of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1987; 59(11):66-71. PubMed ID: 3441869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of diffuse membranous glomerulonephritis with a combination of anticoagulants and corticosteroids].
    Belovezhdov N
    Vutr Boles; 1984; 23(5):59-67. PubMed ID: 6523843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors influencing the results of chronic glomerulonephritis treatment].
    Riabov SI; Stavskaia VV; Chistova EK; Ashkinazi RI; Zaitseva NI; Kravchenko NP; Mozgovaia AN; Sashurina SN
    Klin Med (Mosk); 1997; 75(2):38-42. PubMed ID: 9157214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the filtration function of the kidneys during the treatment of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Kozlov VV; Kucher AG
    Ter Arkh; 1994; 66(8):52-7. PubMed ID: 7985156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New results concerning the effectiveness of therapy of chronic glomerulonephritis. Results of cytostatics-anticoagulants-aggregation inhibitors, cystostatics-anticoagulants-aggregation inhibitors-prednisone and cystostatics-prednisone therapy, derived from a retrospective study].
    Sinn W; Ratner M; Tomilina N; Klinkmann H; Nizze H
    Z Urol Nephrol; 1986 Aug; 79(8):449-57. PubMed ID: 3535293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of pathogenetic therapy on the expression of endogenous intoxication in patients with chronic glomerulonephritis].
    Rumiantsev ISh; Kaznacheeva IG; Abdiadilova LV; Kozlov VV
    Ter Arkh; 1992; 64(6):35-9. PubMed ID: 1440334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immediate results of using plasmapheresis in patients with chronic glomerulonephritis].
    Dorofeev SB; Tov NL; Movchan EA; Valentik MF; Sidorova LD
    Ter Arkh; 1991; 63(10):119-22. PubMed ID: 1805408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination].
    Schmitt E; Kröger E; Lakner V; Klinkmann H; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1979 Sep; 34(17):465-71. PubMed ID: 539014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Our experience in the combined pathogenetic treatment of chronic glomerulonephritis.
    Dimitrakov D; Kumchev E; Tzekov V; Manev E; Tzvetkova Z; Tilkyan E; Pandeva S; Nikolov D
    Folia Med (Plovdiv); 1998; 40(2):67-73. PubMed ID: 9707816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
    Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of the clinical classification of chronic glomerulonephritis for the prognosis of its progression and of the efficacy of therapy].
    Ratner MIa; Serov VV; Stenina IN; Fedorova ND; Shumakov VI
    Ter Arkh; 1996; 68(6):10-3. PubMed ID: 8771673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic glomerulonephritis with cytostatics].
    Tareeva IE; Gordovskaia NB; Gladskikh OP; Ivanov AA; Krasnova TN
    Ter Arkh; 1989; 61(6):9-14. PubMed ID: 2799726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potentials of the modern pathogenetic treatment of immune glomerulonephritis].
    Belovezhdov N
    Vutr Boles; 1978; 17(5):12-20. PubMed ID: 716367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tubulointerstitial component of chronic glomerulonephritis. Clinico-morphological comparisons].
    Tov NL; Valentik MF; Vakulin GM; Kagalovskaia IM; Sasin AV
    Ter Arkh; 1985; 57(6):32-6. PubMed ID: 4071409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The course of chronic glomerulonephritis in chronic opisthorchiasis].
    Beloborodova EI; Zibnitskaia LI; Kaliuzhina EV
    Ter Arkh; 2005; 77(11):44-9. PubMed ID: 16404862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.